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Penile squamous cell carcinoma (SCC) is uncommon 
(1, 2). Two distinct pathways lead to penile SCC: one 
is linked to human papillomavirus (HPV) infection and 
is associated with undifferentiated penile intraepithelial 
neoplasia (PeIN); the other is linked to non-neoplastic 
epithelial disorders, such as epithelial hyperplasia or li-
chen sclerosus (LS) and is associated with differentiated 
PeIN (3–7). Little is known about molecular changes in 
the genesis of penile cancer. Only one study has reported 
the expression of hormonal receptors, such as oestrogen 
receptors (ERα), and androgen receptor (AR) in normal 
penile epithelium, with no sign of progesterone receptor 
(PR) expression (8). Thus far, however, no studies have 
investigated the possible role of these receptors in the 
transition from normal epithelium to male genital LS or 
penile SCC. 
The aims of the present study were to describe his-
tological and immunohistochemical features of SCCs, 
to examine the modulation of hormonal receptors ERα, 
AR, PR and molecular proliferation markers (p53 and 
Ki-67) in normal penile epithelium and in SCC, and to 
extend this evaluation to penile lesions adjacent to SCC.
MATERIALS AND METHODS
This retrospective study was conducted on 21 consecutive patients 
who had undergone surgical resection of penile cancer in San 
Martino Polyclinic Hospital, Genoa, Italy, in the period 2006 to 
2015. All the curative-intended surgical specimens (wide exci-
sional biopsies, partial and total penectomies) were fixed in 10% 
buffered formalin, processed and embedded in paraffin to obtain 
haematoxylin-eosin-stained slides. In each case, a representative 
block containing both normal (NE) and tumour tissue (K), as well 
as the SCC-associated penile lesion (PRE), was chosen in order 
to obtain further sections. Squamous multi-layered epithelium 
devoid of major inflammation, and displaying normally orienta-
ted cellular maturation, was considered normal epithelium (NE). 
Squamous cell hyperplasia was defined as epithelial hyperplasia 
and hyperkeratosis, increased mitotic figures in basal and prickle 
cell layers and mild dermal chronic inflammation, with no aty-
pia. Lichen sclerosus was defined as severe hyperkeratosis, thin 
epidermis and presence of a homogenized band of dense fibrosis 
affecting the papillary dermis. Differentiated PeIN was defined 
as hyperkeratosis, hypergranulosis, acanthosis, with cytological 
atypia. SCC was defined as variable cytological atypia, high 
mitotic index, infiltrating pattern and presence of keratin pearls. 
The following antibodies were used for immunohistochemistry 
testing: Androgen Receptor (Cell Marque, Rocklin, USA,  Clone 
SP107, pre-diluted), Estrogen Receptor α (Ventana, Innovation 
Park Dr. Tucson, USA, Clone SP1, pre-diluted), Ki67 (Ventana, 
Clone 30-9, prediluted), Progesterone Receptor (Ventana, Clone 
1E2, pre-diluted), p53 (Ventana, Clone DO-7, prediluted). Appro-
priate negative and positive controls were implemented according 
to the manufacturer’s data-sheets. Expression was evaluated by 
considering the percentage of cells exhibiting immunoreactivity 
as well as intracellular localization. In normal tissue and in SCC-
associated penile lesions, analysis was restricted to the epithelial 
component, where the number of positive (brown-stained) cells 
in a random field of 300 cells was counted; the reactivity pattern 
of cell positivity was also recorded (i.e. basal, lower, middle and 
upper thirds of the epithelium, or diffuse). In tumours, the number 
of positive cells was counted in 5 separate fields of 100 cells each 
(total number 500 tumour cells). The results were expressed as 
the mean percentages of positively stained nuclei in relation to 
the total number of epithelial- or tumour-cell nuclei considered. 
The staining intensity was not evaluated. 
RESULTS
Clinical-pathological features of the study population 
are shown in Table SI1.
Immunohistochemistry
Androgen receptor. In NE, SCC-associated lesions 
and SCCs, AR expression displayed mean ± standard 
deviation (SD) values of 52.0 ± 32.7%, 28.1 ± 28.0% 
and 0.9 ± 3.0% labelled cells, respectively. Moreover, 
positivity in SCCs was confined to the lower third of the 
epithelium; in SCC-associated lesions, the distribution 
of positivity was variable; in NE, positivity was diffuse. 
Significant differences (p < 0.001) in staining indexes 
was observed between NE and K and between PRE 
and K. Although the AR staining index proved lower in 
PRE than in NE, the difference failed to reach statistical 
significance (Fig. S11).
Oestrogen receptors α and progesterone receptor. ERα 
immunoreactivity was recognized in 5 cases only, and 
was very weak. None of the specimens tested showed 
substantial expression of PR. 
p53. In NE, SCC-associated lesions and SCCs, p53 
expression displayed mean ± SD values of 2.8 ± 5.0%, 
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7.5 ± 21.8% and 24.3 ± 31.4% labelled cells, respecti-
vely. These differences proved statistically significant 
(p < 0.001) on comparing SCC with NE or with associated 
lesions, but not on comparing NE with associated lesions. 
Ki-67. In NE, SCC-associated lesions and SCCs, Ki-67 
expression displayed mean ± SD values of 5.6 ± 3.6%, 
12.9 ± 9.8% and 30.5 ± 14.6% labelled cells, respectively. 
Moreover, positivity in NE was confined to the lower 
third of the epithelium; in SCC-associated lesions, po-
sitivity was seen in both the lower and the middle thirds 
of the epithelium; in SCCs, positivity was widespread. 
Significant differences in staining indexes were observed 
between NE and K and between PRE and K (p < 0.001). 
Although the Ki67 staining index was higher in PRE 
than in NE, the difference failed to reach statistical 
significance. 
DISCUSSION
Twenty-one patients underwent surgical resection of 
penile cancer in the 10-year period, confirming that 
this disease is uncommon. LS features were found in 
more than half (57.1%) of specimens, confirming LS 
as an SCC-associated lesion, regardless of its clinical 
diagnosis. Indeed, according to the literature, up to 50% 
of SCC are associated with LS (9–11); in the present 
study, however, we found a closer association. Cases of 
differentiated PeIN not associated with LS as a precursor 
lesion accounted for only a minority of patients. No cases 
of HPV-related types of SCC were found, and none of the 
specimens showed signs of HPV infection; nevertheless, 
we are aware that, since specific immunohistochemical 
or molecular investigations were not performed, HPV 
infection cannot be definitely excluded. In this study, a 
statistically significant loss of AR expression was found 
in the transition from normal epithelium to SCC-asso-
ciated lesion and from this latter to penile malignancy. 
Distribution of immunopositivity also decreased; in 
normal epithelium, it was diffuse, whereas it was less 
extensive in SCC-associated lesions and totally absent 
in cancer. The more cells that were labelled, the broader 
the immunopositivity became. The present study is the 
first to describe this kind of decrease in AR expression 
in penile cancer. As expected, the increase in Ki-67 and 
p53 expression in the transition from normal epithelium 
to SCC-associated lesion, and from this latter to penile 
malignancy, indicates an increase in proliferative activity. 
An increase was also found in SCC-associated lesions in 
comparison with normal epithelium. In this case, howe-
ver, statistical significance was not reached, although it 
was expected, at least for p53 in LS cases, on the basis 
of previous studies (12). With the progression of transi-
tion, Ki-67 immunopositivity spread from basal layers 
to the upper third of the epithelium, more evidently in 
less differentiated tumours. ERα and PR did not yield 
interesting results. ERα was rarely, and weakly, positive 
in normal epithelium and in pre-neoplastic lesions, and 
PR was not expressed in NE, PRE or K. In fact, according 
to the scant literature, ERα should be positive in normal 
penile epithelium (8).
In conclusion, our preliminary study demonstrates that 
the transition from normal epithelium to penile cancer 
is characterized by a significant loss of AR expression. 
These results, if confirmed by larger studies, may sug-
gest using topical androgen-based products in patients 
with genital lesions at high-risk for cancer development.
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Fig. S1. Penile carcinoma and associated lesions: androgen receptor 
(AR). Top: the AR-staining indexes of normal epithelium, pre-neoplastic 
changes and invasive cancer are compared by means of bar plots. Bottom: 
representative immunohistochemical staining for the AR samples (original 
magnification 100×). Observe the lower AR molecular expression in the 
invasive cancer sample.
Table SI. Clinical-pathological features of study population
Feature
Normal epithelium, n 21




Mixed (with sebaceous areas) 1
  with associated squamous cell hyperplasia 7
  with associated lichen sclerosus 12
  with associated differentiated penile intraepithelial neoplasia 2
Age, years, median (range) 70 (52–87)
T, n (%)
  Tis 2 (9.5)
  T1a 5 (23.8)
  T2 7 (33.3)
  T3 7 (33.3)
Grade, n (%)
  1 7 (33.3)
  2 5 (23.8)
  3 9 (42.9)
Loco-regional lymph node status, n (%)
  Negative 1 (4.8)
  Positive 1 (4.8)
  Unknown node status (no lymphadenectomy) 19 (90.5)
